The FDA Just Released a Major Warning to These Beauty and Health Companies for Committing 'Health Fraud'

The FDA Just Released a Major Warning to These Beauty and Health Companies for Committing 'Health Fraud'

The Food and Drug Administration (FDA)
has just reprimanded four major companies for their claims surrounding cannabis-based
products and their effects on cancer.

In a press announcement released by the
FDA on November 1, 2017, four companies—Greenroads Health,
Natural Alchemist, That’s Natural! Marketing and Consulting, and Stanley
Brothers Social Enterprises LLC
—are being accused of engaging in “deceptive marketing” and “health
fraud” due to their claims that their cannabidiol (CBD) products
could help treat cancer patients.

You May Also Like: FDA Cracks Down on Stem Cell Treatments

“The FDA
has grown increasingly concerned at the proliferation of products claiming to
treat or cure serious diseases like cancer,” the press release said. “The
deceptive marketing of unproven treatments may keep some patients from
accessing appropriate, recognized therapies to treat serious and even fatal

To combat these false statements, the FDA issued warning letters to
the companies in question and publicly announced their specific violations, some of which include
claims that their products do the following: “combat tumor and cancer cells, make cancer cells commit ‘suicide’ without killing other cells, has anti-proliferative properties that inhibit cell division and growth in certain
types of cancer, and may be effective in treating tumors from cancer—including
breast cancer.”

Clearly these claims can be dangerous,
especially if patients choose to forgo traditional cancer treatments and opt to trust these products as their solution instead. “We don’t let companies market products that
deliberately prey on sick people with baseless claims that their substance can
shrink or cure cancer and we’re not going to look the other way on enforcing
these principles when it comes to marijuana-containing products,” said FDA
Commissioner Scott Gottlieb, MD. “When people are allowed to illegally
market agents that deliver no established benefit they may steer patients away
from products that have proven, anti-tumor effects that could extend lives.”

While there has been a lot of buzz
surrounding the usage of marijuana in cancer remedies, there is no sufficient, scientific evidence to support the idea that cannabis can cure cancer. “We
recognize that there’s interest in developing therapies from marijuana and its
components, but the safest way for this to occur is through the drug approval
process—not through unsubstantiated claims made on a website,” concluded

The FDA is requesting that the companies under scrutiny respond to the recent warning
letters with ways in which they will correct the violations listed above.
If they choose to ignore the agency’s request, they may be met with “legal action, including
product seizure and injection.”

By | 2017-11-08T01:42:31+00:00 November 8th, 2017|Categories: Plastic Surgery|0 Comments

Leave A Comment